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MK-801Nandrolone decanoate (ND), an anabolic androgenic steroid (AAS), induces an aggressive phenotype bymecha-
nisms involving glutamate-induced N-methyl-D-aspartate receptor (NMDAr) hyperexcitability. The astrocytic
glutamate transporters remove excessive glutamate surrounding the synapse. However, the impact of
supraphysiological doses of ND on glutamate transporters activity remains elusive. We investigated whether
ND-induced aggressive behavior is interconnected with GLT-1 activity, glutamate levels and abnormal NMDAr
responses. Two-month-old untreated male mice (CF1, n = 20) were tested for baseline aggressive behavior in
the resident–intruder test. Another group of mice (n = 188) was injected with ND (15 mg/kg) or vehicle for 4,
11 and 19 days (short-, mid- and long-term endpoints, respectively) and was evaluated in the resident–intruder
test. Each endpoint was assessed for GLT-1 expression and glutamate uptake activity in the frontoparietal cortex
and hippocampal tissues. Only the long-term ND endpoint signiﬁcantly decreased the latency to ﬁrst attack and
increased the number of attacks, which was associated with decreased GLT-1 expression and glutamate uptake
activity in both brain areas. These alterations may affect extracellular glutamate levels and receptor excitability.
Residentmaleswere assessed for hippocampal glutamate levels viamicrodialysis bothprior to, and following, the
introduction of intruders. Long-term ND mice displayed signiﬁcant increases in the microdialysate glutamate
levels only after exposure to intruders. A single intraperitoneal dose of the NMDAr antagonists, memantine or
MK-801, shortly before the intruder test decreased aggressive behavior. In summary, long-term ND-induced ag-
gressive behavior is associated with decreased extracellular glutamate clearance and NMDAr hyperexcitability,
emphasizing the role of this receptor in mediating aggression mechanisms.
© 2014 Elsevier Inc. All rights reserved.Introduction
Anabolic androgenic steroids (AAS), such as nandrolone decanoate
(ND), are synthetic derivatives of testosterone that were developed to
improve anabolic functions with fewer androgenic effects (Jones and
Lopez, 2006; Shahidi, 2001). However, humans and rodents submitted
to high AAS dose regimens may display exaggerated emotional reactiv-
ity and aggressive behavior, which ultimately is associated with gluta-
matergic hyperexcitability in brain areas such as the hypothalamus,
cortex, and hippocampus (Breuer et al., 2001; Carrillo et al., 2009,
2011a; Diano et al., 1997; Kanayama et al., 2010; Le Greves et al.,
1997; McGinnis, 2004; Ricci et al., 2007; Robinson et al., 2012; Talih
et al., 2007).try, ICBS, UFRGS, 2600 Ramiro
085544.
.The mechanism underlying the AAS-induced aggressive phenotype
is dynamic and not restricted to proteins of the synaptic milieu. For in-
stance, select hypothalamic neurons express dramatic increases in
phosphate-activated glutaminase, the rate-limiting enzyme in the syn-
thesis of glutamate, in aggressive, adolescent, AAS-treated, male
Syrian hamsters (Fischer et al., 2007). Steroids also increase the rate of
glutamate and aspartate release, thus increasing the binding probability
of glutamate to NMDA or AMPA receptors (Brann and Mahesh, 1995;
Ventriglia and Di Maio, 2013). Actually, AAS-induced aggression is
mechanistically associated with glutamatergic hyperexcitability. This
concept has been supported by studies on genetically modiﬁed animals
and pharmacological studies addressing glutamate fast-acting
ionotropic receptors, i.e. kainate (KAr), α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPAr), and N-methyl-D-aspartate
(NMDAr) (Fischer et al., 2007). To date, studies on knockout mice lack-
ing the AMPAr 1 subunit (GluR1) show reduced aggressive behavior
(Vekovischeva et al., 2004), whereas AAS-treated aggressive hamsters
384 E. Kalinine et al. / Hormones and Behavior 66 (2014) 383–392display a signiﬁcant increase in the number and density of GluR1-
expressing hypothalamic neurons compared to non-aggressive,
vehicle-treated controls (Fischer et al., 2007). Moreover, hypothalamic
administration of a KAr agonist or L-glutamate stimulates aggressive at-
tacks in rats and cats respectively (Brody et al., 1969; Haller et al., 1998).
Although pharmacological antagonism of NMDAr may cause non-
speciﬁc behavioral effects due to sedation, this receptor has multiple
regulatory binding sites that may serve as anti-aggressive targets
(Bortolato et al., 2012; Umukoro et al., 2013). Accordingly, the adminis-
tration of memantine (MEM), a low-afﬁnity uncompetitive NMDAr an-
tagonist, decreases aggression induced by social isolation or morphine
withdrawal in rodents (Belozertseva et al., 1999; Sukhotina and
Bespalov, 2000). Moreover, knockout mice for monoamino oxidase ‘A’
exhibited pathological aggressive behavior mediated by the higher ex-
pression of NR2A and NR2B subunits of NMDAr in the prefrontal cortex
(Bortolato et al., 2012). Remarkably, systemic administration of selective
NR2A andNR2B antagonists as well as dizocilpine (MK-801) an uncom-
petitive high-afﬁnity NMDAr antagonist, countered the enhanced ag-
gression (Bortolato et al., 2012). Collectively, these studies highlight a
positive correlation between heightened aggression and increased glu-
tamatergic tonus in a range of animal models.
Because there are no extracellular enzymes that can degrade gluta-
mate, the maintenance of physiological concentrations requires gluta-
mate transporters activity present in both astrocytes and neurons. The
high-afﬁnity glutamate transporter 1 (GLT-1) is predominantly
expressed in astrocytes and is responsible for more than 90% of gluta-
mate clearance from the synaptic cleft (Lehre and Danbolt, 1998). Fur-
ther, GLT-1 is highest expressed in the hippocampus and neocorticalFig. 1. Schematic experimental design. Behavioral and neurochemical endpoints in control (CO
long-term exposure); (B) Flowchart representing behavioral and biochemical outcomes for eac
after long-term exposure. Abbreviations: high-performance liquid chromatography (HPLC), mareas (Ullensvang et al., 1997). In contrast, glutamate transporter 3
(EAAC1) is widely distributed in neurons and even GLT-1 can be
found at lower levels in neurons, particularly in axon terminals. Despite
neuronal EAAC1 being quantitatively lower when compared to astro-
cytes, its functional role cannot be neglected. Notably, it can be assumed
that astrocytes (via GLT-1) are the main regulators of extracellular glu-
tamate levels (Danbolt, 2001). Although astrocytic glutamate uptake is
recognized as an important mechanism to avoid excessive glutamate
levels associated with prolonged receptor activation, the impact of
supraphysiological doses of ND on glutamate transporters activity re-
mains elusive.
Here, we investigate whether ND-induced aggression is mechanisti-
cally interconnected with GLT-1 activity, glutamate levels, and NMDAr
response in the brains of male, gonad-intact CF1 mice.
Material and methods
Animals
Two-month old CF1 male mice (total n = 208) weighting 32–38 g
were housed in standard polycarbonate cages (cm: 28 × 17.8 × 12.7),
and kept in a temperature-controlled room (22 ± 1 °C) with a 12 h
light/12 h dark cycle (light on at 7 a.m.). The animals were permitted
free access to food and water. To avoid social isolation, both resident
and intruder mice were housed at four per cage (Leasure and Decker,
2009). All experimental procedures were performed according to the
NIHGuide for Care andUse of Laboratory Animals and theBrazilian Society
for Neuroscience and Behavior (SBNeC). Recommendations for animal) and nandrolone (ND) groups: (A) The timeline showing each endpoint (short-, mid- and
h endpoint; (C) Boxes with arrows representing ﬁve independent experiments conducted
emantine (MEM), dizocilpine (MK-801), intraperitoneal (i.p.).
385E. Kalinine et al. / Hormones and Behavior 66 (2014) 383–392care were followed throughout all the experiments in accordance with
project approved by the ethical committee from the Federal University
of Rio Grande do Sul-UFRGS #26739.
Experimental design and drug administration
All experimental procedures are shown in Fig. 1: (A) The timeline
showing each endpoint (short-, mid- and long-term exposure);
(B) Flowchart representing behavioral and biochemical outcomes for
each endpoint; and (C) Boxes with arrows representing ﬁve indepen-
dent experiments conducted after long-term exposure.
The mice home cages were allocated in one of the following groups;
resident or intruder. Resident mice home cages were assigned to treat-
ment groups. Animals received single daily subcutaneous injections of
oil-vehicle (CO) or nandrolone decanoate 50 mg (ND; Deca-Durabolin®,
Organon; 15 mg/kg/day in a volume of 1 ml/kg, dissolved in corn oil)
for 4 days (short-term exposure), 11 days (mid-term exposure) and
19 days (long-term exposure). The ND and CO-treated animals were
not housed in the same cage. This strategy avoids NDmice establishing
social dominance over CO animals before the intruder test. The dose and
treatment regimenwere based on previous publishedworks (Le Greves
et al., 1997; Rossbach et al., 2007). All the behavioral experiments were
conducted during light phase, from 9 a.m. to 3 p.m. (de Almeida et al.,
2010) whereas the vehicle and ND were administered from 3 p.m. to
4 p.m. Thus, the last injectionwas performed on the day prior to the be-
havioral and neurochemical experiments.
The NMDAr antagonist memantine (MEM; Sigma-Aldrich, M183),
and dizocilpine (MK-801; Sigma-Aldrich, M107) were dissolved in sa-
line 0.9%, and were administered intraperitoneally (i.p.) using a single
injection volume of 10 ml/kg. The time of peak concentration (60 min)
in the rat brain after MEM administration was chosen based on the
work of Kotermanski et al. (2013). The dose of MEM (20 mg/kg) was
based on the neuroprotective effects achieved in a rat model of gluta-
matergic hyperexcitability (Zimmer et al., 2012b). The time and dose
regimen of MK-801 (0.1 mg/kg) were based on previous published
work (Bortolato et al., 2012).
Open-ﬁeld test
Animals (n = 10 per group/n = 20 per endpoint) were tested for
spontaneous and locomotor activity after short, mid and long-term CO
or ND administration using a black box apparatus 50 cm × 50 cm ×
50 cm. The experiments were conducted in a sound-attenuated room
under low-intensity light (12 lx). Animals were placed in the right cor-
ner of the arena and locomotor activity was recorded with a video cam-
era for 10 min (Prut and Belzung, 2003). All analyses were performed
using a computer-operated tracking system (Any-maze, Stoelting,
Woods Dale, IL) (see Supplementary material for detailed description).
Additionally, an independent group of mice were long-term
treated with ND or vehicle (CO) and received an i.p. injection of MEM
(20 mg/kg) or saline, 60 min before the open-ﬁeld test (Kotermanski
et al., 2013). Animals were assigned to one of the following groups:
control + saline (CO + SAL), control + memantine (CO + MEM),
ND + saline (ND + SAL) and ND + memantine (ND + MEM); n = 9
per group.
Morris water maze task
We performed theMorris water maze task (MWM) to evaluate spa-
tial memory performance in one independent group of long-term treat-
ed animals. The apparatus was a black, circular pool (110 cm diameter)
with a water temperature of 21± 1 °C. The long-term CO (n= 10) and
ND mice (n = 10) were trained daily in a four-trial MWM for ﬁve con-
secutive days; each trial lasted up to 60 s and was followed by 20 s of
rest on a hidden black platform. During training, mice learned to escape
from the water by ﬁnding a hidden, rigid, black platform submergedabout 1 cm below the water surface in a ﬁxed location. If the animal
failed to ﬁnd the platform in 60 s, it was manually placed on the plat-
form and allowed to rest for 20 s. Each trial was separated by at least
12 min to avoid hypothermia and facilitate memory acquisition
(Muller et al., 2011), see Supplementary Fig. 2.Resident–intruder test
In this test, aggressive behavior is tested by introducing an intruder
into a resident's home cage. As expected, residents are typically more
aggressive because they are familiar with the environment and are
defending their home territory (Nelson and Trainor, 2007). The protocol
of the intruder test used in this studywas adapted from a previouswork
of our group (Kazlauckas et al., 2005). To date, dominant or subordinate
animalswere not distinguished before the test. If the intruder animal at-
tacks the resident ﬁrst (~10% of intruders) or showed an exacerbated
offensive proﬁle, both animals were excluded from the analysis and
were not retested. Thus, all residents attacking the intruder were con-
sidered dominant. The test was performed during the light phase
based on previous work of Bortolato et al. (2012) and in the proposed
concept that light or dark phases produce reliable results in social be-
havior testing (Yang et al., 2008). As cited above the mice home cages
were assigned as resident (ND or vehicle) or intruder.
Two days prior to the intruder test, the home cage sawdust of ND
and CO groups was not changed in order for the animals to establish
and maintain territoriality within their home cage. Before the test,
three resident CF1 mice were removed to an identical and clean cage.
One residentmouse remained alone for 2min habituation prior to intro-
ducing the intruder mouse. After testing, the animal number one was
moved to the clean cage. For each ND one CO mouse was assessed in
the intruder test. The ND and CO animals were tested in their own
home cages. The time-delay between each animal test was 15 min, in-
cluding the ﬁrst 2 min habituation. Observations of dominant and sub-
ordinate status, latency to the ﬁrst aggressive attack, and the number
of attacks of the resident toward the intruder were recorded during a
period of 10 min maximum. In this work, an attack was deﬁned as a
bout of activity (ﬁght) lasting up to several seconds during which the
resident mouse bites the intruder at least once. The behaviors that can
be displayed bymice consist of a stationary one-sided attack, frontal at-
tack, chase, wrestle, lunge or boxing inﬂicted by the resident against the
intruder. These components were then recorded as the number of ag-
gressive acts (adapted from Thurmond, 1975).
The intruders did not receive any treatment and were housed in dif-
ferent home cages than were the residents (ND or CO). Residents and
intruders were submitted to the resident–intruder test only once. For
ethical reasons, if the aggressive behavior put the animals at risk of inju-
ries like blooding or suffering the testwas stopped earlier than themax-
imum test duration of 10 min and both resident and intruder animals
were excluded from the analysis (Defensor et al., 2012; Kazlauckas
et al., 2005; Simon and Whalen, 1986; Thurmond, 1975).
To characterize the baseline aggressive behavior, three groups of
untreated two-month old male mice were subjected to the resident–
intruder test for 10 min, with intervals of 48 h (day 1; n = 6, day 2;
n = 7 and day 3; n = 7). The aggressive scores of each group did not
vary signiﬁcantly across three independent experiments. The mean la-
tency to ﬁrst attack was 471.5 ± 42.7 s (S.E.M.), and the mean number
of attacks was 2.10 ± 0.65 (S.E.M.).
After that, another group of mice was injected with vehicle (CO) or
ND and tested for aggressive behavior at short-, mid- and long-term
exposures (n = 10 per group/per endpoint). In addition, another
group of long-term ND and CO mice received a single i.p. injection of
MEM (20 mg/kg) or saline 60 min before the resident–intruder test
(Kotermanski et al., 2013). For this approach, animals were assigned
to the following groups: CO + SAL, CO + MEM, ND + SAL and ND +
MEM (n= 6 per group, total n = 24).
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withMK-801 (0.1 mg/kg) or saline 30min before the resident–intruder
test (Bortolato et al., 2012). Animalswere then assigned to the following
groups: CO+SAL, CO+ MK-801, ND+SAL andND+MK-801 (n=10
per group, total n = 40).
Sodium-dependent glutamate uptake activity
After short-,mid- and long-termvehicle (CO) orND exposure (n=6
per group) animals were decapitated and the right hippocampus and
frontoparietal cortex were immediately dissected on ice (4 °C). Slices
from the hippocampus and frontoparietal cortex (0.4 mm thick) were
rapidly prepared using a McIlwain Tissue Chopper, separated in HBSS
(in mM: 137 NaCl, 0.63 Na2HPO4, 4.17 NaHCO3, 5.36 KCl, 0.44 KH2PO4,
1.26 CaCl2, 0.41MgSO4, 0.49MgCl2 and 1.11 glucose, pH 7.2) at 4 °C. Hip-
pocampal and frontoparietal cortical sliceswere pre-incubatedwithHBSS
at 37 °C for 15 min, followed by the addition of 0.33 μCi ml−1 L-[3H]
glutamate (PerkinElmer®). Incubationwas stopped after 5min for hippo-
campus and 7min for frontoparietal cortexwith 2 ice-coldwashes of 1ml
HBSS. Afterwashing, 0.5NNaOHwas immediately added to the slices and
they were stored overnight. Na+-independent uptake was measured
using the above-described protocol with alterations in the temperature
(4 °C) and the composition of the medium (N-methyl-D-glucamine
instead of NaCl). Results (Na+-dependent uptake) were measured as
the difference between the total uptake and the Na+-independent up-
take. Each incubation was performed in quadruplicate (Thomazi et al.,
2004). Incorporated radioactivity was measured using a liquid scintilla-
tion counter (Hidex 300 SL).
Cell viability
Mice (n = 5 per group) were decapitated after long-term expo-
sure and the right hippocampus and frontoparietal cortex were im-
mediately dissected on ice (4 °C). Cellular viability was measured
in brain slices (0.4 mm thick) by MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) assay (Oliveira et al., 2002) (for
detailed description of MTT assay, see Supplementary material). Active
mitochondrial dehydrogenases from living cells are able to reduce MTT
to form a purple formazan product. This is feasible method for measur-
ing cell proliferation and neural cytotoxicity in response to drugs.
Western blotting
Mice (n=6–8 per group) exposed to short-, mid- and long-termND
were decapitated and the left hippocampus and frontoparietal cortex
were immediately dissected on ice (4 °C) and stored at−80 °C for ho-
mogenate preparations. Hippocampal and frontoparietal cortical
homogenates were prepared in PIK buffer (1% NP-40, 150 mM NaCl,
20 mM Tris pH 7.4, 10% glycerol, 1 mM CaCl2, 1 mM MgCl2 and 0.1%
phosphatase inhibitor cocktails I and II; Sigma-Aldrich, USA) at 4 °C,
and centrifuged. Supernatants were collected and the total protein
was measured using the method described by Peterson (1977). For
Western blot analysis, 20 μg of protein from hippocampus and
frontoparietal cortex homogenate preparations was loaded into each
well, separated by electrophoresis on 8% polyacrylamide gel and
electrotransferred to PVDF (polyvinyl diﬂuoride, Thermo Scientiﬁc
Pearce) membranes. Protein bands within each sample lane were com-
pared to standard molecular weight markers (Precision Plus Protein™
Dual Color Standards, Bio-rad), which were used to identify the molec-
ular weight of proteins of interest. Nonspeciﬁc binding sites were
blocked with Tween-Tris buffered saline (TTBS, 100 mM Tris–HCl,
pH 7.5) containing 5% bovine albumin serum (Sigma-Aldrich, USA) for
2 h and then incubated overnight at 4 °C with polyclonal antibody
against GLT-1 dissolved in TTBS (1:1000, Alpha Diagnostic Internation-
al) andmonoclonal antibody anti-β-actin (1:3000, Sigma-Aldrich, USA).
Membranes were then rinsed 3× for 10 min with TTBS and incubatedwith secondary antibodies horseradish peroxidase-conjugated second-
ary antibody (1:3000 dilution, anti-rabbit and 1:3000 dilution anti-
mouse, GE Healthcare Life Sciences) for 2 h at room temperature, mem-
branes were then rinsed 4× for 10 min with TTBS and incubated with
enhanced chemiluminescent substrate (PerkinElmer®) for 1 min or
2min at room temperature. The resulting reactionwas displayed on au-
toradiographic ﬁlm by chemiluminescence (Moreira et al., 2011; Muller
et al., 2011). The X-ray ﬁlms (Kodak X-Omat, Rochester, NY, USA) were
scanned and band intensity was analyzed using Image J software (de-
veloped at the US National Institutes of Health and available on the In-
ternet at http://rsb.info.nih.gov/nih-image).
Microdialysis
Long-termND and COmice (n=4 per group)were implantedwith a
guide cannula under anesthesiawith ketamine (100 mg/kg) andxylazine
(10 mg/kg) using the following coordinates: anterior = 1.8 mm and
lateral = 1.5 mm (both from the bregma), and ventral = 1.5 mm
(from the skull) (Paxinos and Franklin, 2001). Animals assigned in each
experimental group were randomly chosen from two different cages,
and were not distinguished as being dominant or submissive. The mice
were allowed to recover for 48 h after implantation of the guide cannula.
The location of the dialysis probe was conﬁrmed at the end of the
experiment using a vibratome (Leica, Germany) and magnifying lens.
Animals used for microdialysis were allowed to move freely in their
cages. A microdialysis probe was slowly inserted into the hippocampus
(dentate gyrus-CA3 area) through the guide cannula. The animals were
habituated to microdialysis for 1 h (1 μl/min with artiﬁcial extracellular
ﬂuid aECF; 124 mM NaCl, 3 mM KCl2, 1 mM MgSO4 7H2O, NaHCO3,
2mMCaCl2 H2O, 1mMglucose, buffered at pH7.4) using BASi brainmi-
crodialysis probes (MD-2200-BR2, USA) (Garrido et al., 2012). To ana-
lyze baseline levels of extracellular glutamate, we collected 3 samples
at 10 minute increments. Subsequently, individual animals were ex-
posed to an intruder (as previously described) without aECF perfusion,
and soon afterward four samples in fractions of 10 min were collected
during 40 min to analyze post-test glutamate levels. These animals
were used only for microdialysate sampling. Glutamate concentration
was analyzed through high-performance liquid chromatography
(HPLC).
HPLC procedure
HPLC was performed with cell-free supernatant aliquots to quantify
glutamate levels (Schmidt et al., 2009). Brieﬂy, samples were
derivatized with o-phthalaldehyde and separation was carried out
with a reverse phase column (Supelcosil LC-18, 250 mm × 4.6 mm,
Supelco) in a Shimadzu Instruments liquid chromatograph (200 μl
loop valve injection). The mobile phase ﬂowed at a rate of 1.4 ml/min
and column temperature was 24 °C. Buffer composition is A: 0.04 mol/l
sodium dihydrogen phosphate monohydrate buffer, pH 5.5, containing
20% of methanol; and B: 0.01 mol/l sodium dihydrogen phosphate
monohydrate buffer, pH 5.5, containing 80% of methanol. The gradient
proﬁle was modiﬁed according to the content of buffer B in the mobile
phase: 0% at 0.00 min, 25% at 13.75 min, 100% at 15.00–20.00 min, and
0% at 20.01–25.00 min. Absorbance was read at 360 nm and 455 nm,
excitation and emission respectively, in a Shimadzu ﬂuorescence detec-
tor. Samples of 8 μl were used and concentration was expressed in μM.
Biochemical evaluations
After long-term exposure to ND or the vehicle (CO), the animals
(n = 10 per group) were sacriﬁced by decapitation, and then blood
was collected and centrifuged (10,000 ×g, 10 min) to obtain serum
samples. We evaluated serum biochemical parameters linked with
metabolic proﬁle (glucose tolerance test and lipids) and tissue-speciﬁc
toxicity: kidney (urea, creatinine) and liver (albumin, AST; alanine
Fig. 2. Resident–intruder test. Long-term ND exposure (15 mg/kg) induced an exacerbated aggressive behavior in CF1 male mice. (A) Latency to ﬁrst attack (p b 0.0001); (B) Number of
attacks; (p = 0.0168). Data represented mean ± S.E.M. (n = 10 per group). *p = 0.0168 and ***p b 0.0001 indicate signiﬁcant statistical difference between groups.
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2011; Zimmer et al., 2012a) (for detailed description see Supplementa-
ry material).
Statistical analysis
Data distribution was analyzed using the Kolmogorov–Smirnov test.
The Mann–Whitney U-test was used to analyze differences between
each ND endpoint (short-, mid-, long-term) and its respective CO
group in the resident–intruder test. Differences between groups in neu-
rochemical and biochemical parameters were analyzed using Student's
t test. Nonparametric comparisons were performed by the Kruskal–
Wallis test, with Dunn's post-hoc test comparisons to analyze differ-
ences in the resident–intruder test with MEM and MK-801 administra-
tion. The differences between groups were considered statistically
signiﬁcant if p b 0.05. Results were presented as mean ± standard
error of mean (S.E.M.).
The Cohen's d was used to estimate the effect size, which is the dif-
ference betweenmeans divided by standard deviation (S.D.). According
to Cohen's d, effect size was classiﬁed as small (d= 0.2), medium (d=
0.5) and large (d ≥ 0.8) (Sullivan and Feinn, 2012).
Results
Nandrolone-induced aggressive behavior
ND exposure did not cause signiﬁcant decrease in the latency to ﬁrst
attack in short- (p = 0.199; Cohen's d = 0.36), and mid-term expo-
sures (p = 0.662; Cohen's d = 0.28) compared to their respective CO
groups (Fig. 2A). Also, there was no signiﬁcant difference in the number
of attacks in short- (p= 0.372; Cohen's d=−0.25), andmid-term ex-
posures (p= 0.525; Cohen's d=−0.26) compared to their respective
CO groups (Fig. 2B). In contrast, long-term administration of ND signif-
icantly decreased the latency to ﬁrst attack (Fig. 2A, p b 0.0001; Cohen's
d= 1.41), and increased the total number of attacks against an intruder
compared to the CO group (Fig. 2B, p = 0.0168; Cohen's d =−0.77).
For more detailed pairwise comparisons see Table 1.Table 1
Resident–intruder test after vehicle (CO) or nandrolone (ND) administration (short-, mid-, and
Behavior test Time regimen Parameters Control (CO)
Intruder test Short-term exposure Latency to ﬁrst attack (s) 493.6 ± 172.0
Mid-term exposure 393.7 ± 240.6
Long-term exposure 515.9 ± 176.9
Short-term exposure Number of attacks 5.4 ± 9.2
Mid-term exposure 6.6 ± 10.0
Long-term exposure 4.4 ± 9.2
Values are expressed as mean ± S.D.Nandrolone decreased glutamate uptake and immunocontent of GLT-1
Long-termND exposure signiﬁcantly decreased glutamate uptake in
slices of hippocampus (Fig. 3A, p = 0.03; Cohen's d = 1.83) and
frontoparietal cortex (Fig. 3B, p= 0.004; Cohen's d= 1.20) when com-
pared to the CO group. Moreover, the immunoquantiﬁcation of the glu-
tamate transporter 1 (GLT-1) byWestern blotting revealed a signiﬁcant
decrease in hippocampus (Fig. 3C, p = 0.03; Cohen's d = 1.26) and
frontoparietal cortex (Fig. 3D, p = 0.0003; Cohen's d = 2.02). For
more detailed pairwise comparisons see Tables 2 and 3. The decreased
glutamate uptake activity and GLT-1 expression may cause increases
in the glutamate levels associated with hyperstimulation of glutamate
receptors and cell damage and/or dysfunction. Thus, we performed
analyses of cell viability throughMTT assay in slices of frontoparietal
cortex and hippocampus after short- and long-term ND exposures
(n = 5 per group). There was no signiﬁcant difference observed
between the ND and CO groups, suggesting no overt signs of de-
creased neural cells' viability/damage in frontoparietal cortex (short-,
p = 0.577; Cohen's d = 0.39 and long-term, p = 0.682; Cohen's d
= 0.61) and hippocampus (short-, p = 0.629; Cohen's d =−0.29
and long-term, p = 0.579; Cohen's d = 0.42) (see Supplementary
Table 2).
Short- and mid-term exposures to ND or vehicle (CO) (n = 6–8)
did not cause signiﬁcant changes, either in the immunocontent of
GLT-1 in hippocampus (short-, p = 0.785; Cohen's d = 0.10 and
mid-, p = 0.086; Cohen's d = 0.81) and frontoparietal cortex
(short-, p = 0.694; Cohen's d = 0.25 and mid-term, p = 0.069;
Cohen's d = 0.88), or in glutamate-uptake capacity in same brain
areas (data not shown).
Long-term ND exposure increased hippocampal extracellular glutamate
levels
The glutamate levels in the long-term (ND) group not exposed to in-
truder (baseline) did not show statistical signiﬁcant difference com-
pared to the control (CO) group (Fig. 4, p = 0.06; Cohen's d =
−1.70). After exposure to the intruder test, the glutamate levels in the
ND group signiﬁcantly increase compared to CO animals (Fig. 4, p =long-term endpoints, n = 10 per group/per endpoint).
Nandrolone (ND) Cohen's d Statistical difference n per group/per endpoint
422.7 ± 221.8 0.36 n.s. 10
327.0 ± 240.8 0.28 n.s.
227.2 ± 233.4 1.41 p b 0.0001
7.6 ± 9.1 −0.25 n.s.
9.3 ± 11.0 −0.26 n.s.
11.8 ± 10.0 −0.77 p = 0.0168
n Total 60
Fig. 3.Glutamate uptake andWestern blotting. Nandrolone (ND) decreases glutamate uptake and immunocontent of GLT-1 in hippocampus and frontoparietal cortex. (A) Glutamate up-
take in slices of hippocampus, and (B) frontoparietal cortex (n = 6). (C) Immunocontent of GLT-1 in hippocampus and, (D) frontoparietal cortex (n = 6–8). Data represented mean ±
S.E.M. *p= 0.03, **p= 0.004 and ***p= 0.0003 indicate signiﬁcant difference between groups. Short- andmid-termND exposures were not signiﬁcantly different from their respective
control groups.
Table 2
Glutamate uptake in slices of hippocampus and cortex in long-term groups (CO and ND, n = 6 per group).
Neurochemical assay Brain structure Time regimen Control (CO) Nandrolone (ND) Cohen's d Statistical difference n per group/per endpoint
Glutamate uptake Hippocampus Long-term exposure 100.0 ± 11.1 69.56 ± 22.2 1.83 p = 0.03 6
Cortex Long-term exposure 100.0 ± 22.7 70.93 ± 25.7 1.20 p = 0.004
n Total (hippocampus) 12
n Total (cortex) 12
Values are expressed as mean ± S.D.
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lected and glutamate was measured with HPLC. Data represent mean ±
S.E.M. (n = 4 per group). For more detailed comparisons see Table 4.
Memantine and MK-801 decreases aggressive behavior induced by
nandrolone
A single MEM administration after long-term ND exposure did not
cause signiﬁcant changes in the locomotor activity on open-ﬁeld testTable 3
Immunocontent of GLT-1 in homogenates of hippocampus and frontoparietal cortex after vehi
Neurochemical assay Brain structure Time regimen Control (CO)
Western blotting Hippocampus Short-term exposure 100.0 ± 14.0
Mid-term exposure 100.0 ± 18.9
Long-term exposure 100.0 ± 13.9
Cortex Short-term exposure 100.0 ± 15.4
Mid-term exposure 100.0 ± 15.9
Long-term exposure 100.0 ± 11.3
Values are expressed as mean ± S.D., n = 6 for hippocampus and n = 8 for cortex per group(see results in the Supplementary Table 3). This indicates an absence
of sedative effects, which could be a confounding factor in the
resident–intruder.
We additionally investigated the possible connection between in-
creased extracellular glutamate levels and NMDAr hyperexcitability
mediating aggressive behavior. Thus, long-termND+ SAL group signif-
icantly decreased the latency to ﬁrst attack and increased the number of
attacks compared to CO + SAL group (Fig. 5A, p = 0.022; Cohen's d=
2.97 and Fig. 5B, p = 0.0457; Cohen's d = −2.73 respectively). Thecle (CO) or nandrolone (ND) administration (Short-, mid- and long-term endpoints).
Nandrolone (ND) Cohen's d Statistical difference n per group
98.0 ± 24.4 0.10 n.s. 6
84.1 ± 20.2 0.81 n.s.
80.9 ± 16.5 1.26 0.03
96.01 ± 16.3 0.25 n.s. 8
84.98 ± 18.3 0.88 n.s.
80.25 ± 8.3 2.02 p = 0.0003
n Total (hippocampus) 36
n Total (cortex) 48
/per endpoint (short-, mid- and long-term exposures).
Fig. 4.Glutamate levels in extracellularﬂuid of hippocampus. The glutamate levels in long-
term nandrolone (ND) and vehicle (CO) animals not exposed to intruder (baseline). After
exposure to intruder test (post-test), the animals signiﬁcantly increase the glutamate
levels when compared to CO animals (p = 0.04). Extracellular microdialysate ﬂuid was
collected and glutamate was measured with HPLC. Data represent mean ± S.E.M. (n =
4 per group).
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and decreased the number of attacks (Fig. 5A, p = 0.017; Cohen's
d =−2.99 and Fig. 5B, p = 0.003; Cohen's d = 3.50) in ND + MEM
compared to the ND + SAL group, respectively. The MEM per se did
not signiﬁcantly affect the latency to ﬁrst attack or number of attacks
in CO + SAL compared to CO + MEM (Figs. 5A and B, p = 0.999;
Cohen's d= 0.08 and d =−0.04 respectively).
Additionally, long-term ND+ SAL group signiﬁcantly decreased the
latency to ﬁrst attack and increased the number of attacks compared to
CO+ SAL group (Fig. 5C, p = 0.004; Cohen's d= 1.57 and Fig. 5D, p =
0.024; Cohen's d=−1.05 respectively). The administration of MK-801
signiﬁcantly increased the latency to ﬁrst attack and decreased the
number of attacks (Fig. 5C, p = 0.004; Cohen's d = −1.32 and
Fig. 5D, p = 0.002; Cohen's d = 1.38) in ND + MK-801 compared to
ND + SAL group, respectively. As expected, the MK-801 per se did not
signiﬁcantly affect the latency to ﬁrst attack or number of attacks in
CO + SAL compared to CO + MK-801 (Figs. 5C and D, p = 0.999;
Cohen's d =−0.10 and d= 0.22 respectively). These pharmacological
approaches with MEM or MK-801 reinforce the implication of NMDAr
hyperexcitability in the mechanism of aggression For more detailed
pairwise comparisons see Tables 5 and 6.
Biochemical evaluation
Serum biochemical results are presented in Supplementary Table 1.
After long-term exposure, ND signiﬁcantly increased serum levels of tri-
glycerides (p = 0.0468; Cohen's d = −1.32) and decreased HDL-
cholesterol serum levels (p = 0.0017; Cohen's d= 1.46) compared to
the CO. The capacity of mice in regulating glucose homeostasis (GTT)
was not affected by treatments (data not shown). Similarly, there
were no signiﬁcant alterations in serum biochemical markers of liverTable 4
Microdialysis/HPLC in long-term groups (CO and ND) at baseline and after exposed an intrude
Behavior test Time regimen Parameters
Microdialysis/HPLC after and before intruder Long-term exposure Glutamate levels (μM
Values are expressed as mean ± S.D.and kidney damage. The food consumption and body weight gain
during short-term to long-term exposure were similar between groups.
As expected, testicular weight (in grams) was signiﬁcantly decreased in
ND relative to CO (0.291 g ± 0.04 versus 0.251 g ± 0.04, p = 0.007;
Cohen's d= 1.00).Discussion
Our results demonstrate that long-term ND-induced aggressive be-
havior is associated with glutamatergic abnormalities like down-
regulation of astrocytic glutamate uptake and increases in the glutamate
levelsmediatingNMDAr hyperexcitability. In accordance to this, the ad-
ministration of NMDAr antagonists MEM (uncompetitive low-afﬁnity
NMDAr antagonist) and MK-801 (uncompetitive high-afﬁnity NMDAr
antagonist), shortly before the intruder test reduce the aggressive be-
havior in long-term ND group.
Short-, mid- and long-term ND exposures did not affect locomotor
and exploratory activity on open-ﬁeld test (see Supplementary Fig. 1)
indicating that there was no alteration in the motor components of ag-
gressive responding. In fact, studies evaluating putative effects of AAS
on spontaneous locomotion and exploratory proﬁle in rodents have
shown no signiﬁcant changes (see review of Clark and Henderson,
2003). Similarly, the spatial memory performance on MWM in both ac-
quisition and retention phases showed no signiﬁcant differences be-
tween ND and CO groups suggesting normal spatial information
processing (see Supplementary Fig. 2). As the hippocampus participates
in both memory and aggressive behavior and is very sensitive to repet-
itive stress, this evaluation allows ruling out the overlap of hippocampal
responses associated with long-term ND administration. In contrast to
our ﬁndings, long-term administration of ND (15 mg/kg) impairs
MWM performance in both acquisition and retention phases in rats
(Magnusson et al., 2009; Tanehkar et al., 2013). Overall, these behavior-
al outcomes, associated with the lack of differences on kidney and liver
serum biochemical markers (see Supplementary Table 1), strengthen
the view that our long-term ND treatment regimen impacts central
mechanisms associated with aggression without apparent toxic effects
on these organs.
Also, the temporal aggressive proﬁle reported here corroborates
published data by Carrillo et al. (2011a), in which an AAS cocktail in-
duced progressive alterations in the glutamatergic parameters associat-
ed with increased aggressive scores. Glutamatergic neurotransmission
in the hypothalamus is an output aggressive system modulated by go-
nadal hormones and AAS (Brann and Mahesh, 1995; Brody et al.,
1969; Diano et al., 1997; Fischer et al., 2007; Haller, 2013), which also
receives many inputs from different brain areas and neurotransmitter
systems. This implies that the neurobiology of aggressive behavior in-
volves a complex and intricate collaborative network (Carrillo et al.,
2011b; Ferris et al., 2008;Nelson and Trainor, 2007). Accordingly, a neu-
ral circuit composed of several regions including the prefrontal cortex,
amygdala, hippocampus, hypothalamus, anterior cingulated cortex,
and other interconnected structures has been implicated in emotion
regulation. Consequently, functional or structural abnormalities in one
or more of these regions or in the interconnections among them can in-
crease the susceptibility for impulsive aggression and violence (Nelson
and Chiavegatto, 2001). Considering these functional interconnections,r (n = 4 per group).
Time period CO ND Cohen's d Statistical
difference
n per group
) Baseline 4.63 ± 0.92 6.80 ± 1.64 −1.70 p = 0.06 4
Post-test 4.43 ± 1.65 10.30 ± 2.26 −3.00 p = 0.04
n Total 8
Fig. 5. N-methyl-D-aspartate receptor (NMDAr) antagonists and resident-intruder test. Memantine (20 mg/kg i.p.) or MK-801 (0.1 mg/kg i.p.) administration in long-term ND
mice, 60min and 30min respectively prior to intruder test, restores the aggressive scores to levels of the COgroup: (A) Latency to ﬁrst attack (CO+SAL versusND+SAL; p= 0.0219 and
ND+ SAL versus ND+MEM; p = 0.0168) and (B) Number of attacks (CO + SAL versus ND + SAL; p = 0.0457 and ND+ SAL versus ND +MEM; p= 0.0029, n = 6 per group) after
memantine administration; (C) Latency to ﬁrst attack (CO+ SAL versus ND+ SAL; p= 0.0041 and ND+ SAL versus ND+MK-801; p= 0.0041); and (D) Number of attacks (CO+ SAL
versus ND + SAL; p = 0.0239, and ND + SAL versus ND + MK-801; p = 0.0015, n = 10 per group) after MK-801 administration. Data represent mean ± S.E.M. *p b 0.05 indicates
signiﬁcant statistical difference between groups.
Table 5
Resident–intruder test in long-term groups (CO and ND) after a single memantine (MEM) administration (n = 6 per group).
Behavior test Time regimen Parameters CO/SAL CO/MEM ND/SAL ND/MEM Cohen's d Statistical
difference
n per group
Intruder test with MEM Long-term exposure Latency to ﬁrst attack (s) 548.3 ± 59.6 543.3 ± 60.6 0.08 n.s. 6
156.7 ± 203.8 547.7 ± 57.4 −2.99 p = 0.017
548.3 ± 59.6 156.7 ± 203.8 2.97 p = 0.022
543.3 ± 60.6 547.7 ± 57.4 −0.04 n.s.
Number of attacks 3.2 ± 2.6 3.3 ± 1.9 −0.07 n.s.
13.0 ± 4.6 1.8 ± 1.8 3.50 p = 0.003
3.2 ± 2.6 13.0 ± 4.6 −2.73 p = 0.046
3.3 ± 1.9 1.8 ± 1.8 0.81 n.s.
n Total 24
Values are expressed as mean ± S.D. Oil vehicle (CO), nandrolone (ND), saline (SAL) and memantine (MEM, 20 mg/kg). The MEM was administered (i.p.), 60 min before the test.
Table 6
Resident–intruder test in long-term groups (CO and ND) after a single MK-801 administration (n = 10 per group).
Behavior test Time regimen Parameters CO/SAL CO/MK-801 ND/SAL ND/MK-801 Cohen's d Statistical
difference
n per group
Intruder test
with MK-801
Long-term exposure Latency to ﬁrst attack (s) 478.4 ± 164.74 496.3 ± 194.64 −0.10 n.s. 10
180.8 ± 215.39 460.6 ± 207.53 −1.32 p = 0.004
478.4 ± 164.74 180.8 ± 215.39 1.57 p = 0.004
496.3 ± 194.64 460.6 ± 207.53 0.18 n.s.
Number of attacks
3.86 ± 4.40 2.73 ± 6.39 0.22 n.s.
11.28 ± 9.66 2.23 ± 3.54 1.38 p = 0.002
3.86 ± 4.40 11.28 ± 9.66 −1.05 p = 0.024
2.73 ± 6.39 2.23 ± 3.54 0.10 n.s.
n Total 40
Values are expressed as mean ± S.D. Oil vehicle (CO), nandrolone (ND), saline (SAL); dizolcipine (MK-801). The MK-801 (0.1 mg/kg) was administered (i.p.), 30 min before the test.
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aggressive responding is widespread in the brain (Ricci et al., 2007).
Furthermore, long-termND exposure decreased the immunocontent
of GLT-1 and Na+-dependent glutamate uptake activity in the hippo-
campus and frontoparietal cortex, acting as contributory factors to the
observed increase in hippocampal glutamate levels when animals
were exposed to an intruder. These ﬁndings support the concept that
the peak concentration and rate of clearance of glutamate from the syn-
aptic cleft are important determinants of synaptic function (Clements
et al., 1992), and also shed lights for the putative impact of glutamate
transporters dysfunction in the mechanisms of aggression. Considering
that high glutamate levels are implicated in the genesis of aggression
and violent behavior (Munozblanco and Castillo, 1987), and that
NMDAr is a candidate modulator of several behavioral phenotypes, we
conjectured that ND mediates the aggressive responding through
NMDAr.
Therefore, we administratedMEM andMK-801 antagonists to mod-
ulate NMDAr activity and aggression in long-termND exposedmice. Al-
though, theNMDAr antagonists may exhibit a sedative effect (Umukoro
et al., 2013), long-term NDmice injected with MEM (20 mg/kg, 60 min
before the test) did not show a signiﬁcantly reduced locomotor proﬁle
in the open-ﬁeld test, implying that MEM might modulate speciﬁc
mechanisms of aggression without sedative effects. Indeed, the same
dose and time regimen of MEM used in the open-ﬁeld decreased the
aggressive outcomes in the long-term ND mice. It seems clear that
NMDAr antagonism is the primary mechanism of action of therapeutic
relevance for MEM although additional effects at 5-HT3, α-7 nicotinic
acetylcholine and dopamine D2 receptors may be supportive for thera-
peutic effects (Rammes et al., 2008). Thus, the signiﬁcantly reduced ag-
gressive behavior attainedwithMEMmay also include the participation
of these neurotransmitter systems. However, this issue was not ad-
dressed by this study. Similarly to MEM, acute injection of MK-801mit-
igates the aggressive outcomes in long-term ND exposed mice. It is
recognized that MK-801 increases spontaneous locomotion (Bortolato
et al., 2012; Tort et al., 2004), albeit doses up to 0.15 mg/kg barely in-
crease locomotor activity in mice (Su et al., 2007) and rats (Ouagazzal
et al., 1993). Bortolato et al. (2012) showed thatwild-typemice injected
with MK-801 (0.1 mg/kg) caused hyperlocomotion and none anti-
aggressive effects; but despite this the same dose in ourwork decreased
the aggressive outcomes in long-term ND mice. In contrast to our hy-
pothesis, there are studies showing that NMDAr antagonismwith phen-
cyclidine or memantine increases rather than decrease aggressive
behavior (Audet et al., 2009; Newman et al., 2012). Taken together,
these results corroborate the functional relevance of increased brain
glutamate levels and the NMDAr binding sites in the neurobiology of
aggression.Conclusion
In summary, long-term ND-induced aggressive behavior is associat-
edwith decreased extracellular glutamate clearance and NMDAr hyper-
excitability emphasizing the role of this receptor in mediating
mechanisms of aggression.
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